JNJ: Johnson & Johnson Stocks News on April 24, 2025

JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations

JNJ

StockStory

a day ago

JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations

Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income

JNJ

Benzinga

a day ago

Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income

Johnson & Johnson (NYSE:JNJ) Showcases Paradigm-Shifting Bladder Cancer Trials at AUA 2025

JNJ

Simply Wall St.

a day ago

Johnson & Johnson (NYSE:JNJ) Showcases Paradigm-Shifting Bladder Cancer Trials at AUA 2025

Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.30

JNJ

Simply Wall St.

2 days ago

Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.30

Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?

JNJ

StockStory

2 days ago

Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?

JNJ

MT Newswires

3 days ago

Johnson & Johnson to Present Latest Trial Data for TAR-200 to Treat Bladder Cancer

Is Johnson & Johnson (JNJ) the Best American Dividend Stock to Buy According to Analysts?

JNJ

Insider Monkey

3 days ago

Is Johnson & Johnson (JNJ) the Best American Dividend Stock to Buy According to Analysts?

Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA

JNJ

PR Newswire

3 days ago

Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA

Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges

JNJ

Zacks

3 days ago

Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges

JNJ

MT Newswires

3 days ago

Guggenheim Adjusts Price Target on Johnson & Johnson to $164 From $166, Keeps Neutral Rating

Is Johnson & Johnson (JNJ) the Best Low Volatility Stock to Buy Now?

JNJ

Insider Monkey

4 days ago

Is Johnson & Johnson (JNJ) the Best Low Volatility Stock to Buy Now?

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government

JNJ

Motley Fool

4 days ago

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government

JNJ

Benzinga

4 days ago

From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline

Johnson & Johnson (JNJ): Among Value Stocks in Ken Fisher’s Portfolio

JNJ

Insider Monkey

5 days ago

Johnson & Johnson (JNJ): Among Value Stocks in Ken Fisher’s Portfolio

3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now

JNJ

Motley Fool

5 days ago

3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now

Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy

JNJ

Insider Monkey

5 days ago

Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy

Johnson & Johnson Pivots Its AI Strategy

JNJ

The Wall Street Journal

6 days ago

Johnson & Johnson Pivots Its AI Strategy

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock

JNJ

Benzinga

6 days ago

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock

Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025

JNJ

Insider Monkey

7 days ago

Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025

Here's How You Should Play JNJ Stock After Q1 Earnings Beat

JNJ

Zacks

7 days ago

Here's How You Should Play JNJ Stock After Q1 Earnings Beat

Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valley’s version of Johnson & Johnson

JNJ

Fortune

7 days ago

Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valley’s version of Johnson & Johnson

JNJ

Argus Research

7 days ago

Analyst Report: Johnson & Johnson

JNJ

Argus Research

7 days ago

Market Digest: C, FDX, JNJ, PNC

JNJ

MT Newswires

7 days ago

Addex Reclaims Rights to Epilepsy Drug as Janssen Ends Partnership

4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market

JNJ

Motley Fool

7 days ago

4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market

This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row

JNJ

Motley Fool

7 days ago

This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row

Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ

JNJ

Zacks

7 days ago

Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ

Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet”

JNJ

Insider Monkey

8 days ago

Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet”

JNJ

MT Newswires

8 days ago

Raymond James Adjusts Price Target on Johnson & Johnson to $164 From $162, Keeps Outperform Rating

JNJ

MT Newswires

8 days ago

Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $164, Keeps Equalweight Rating

JNJ

MT Newswires

8 days ago

Bernstein Adjusts Price Target on Johnson & Johnson to $159 From $158, Keeps Market Perform Rating

Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ...

JNJ

GuruFocus.com

8 days ago

Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ...

JNJ

Thomson Reuters StreetEvents

8 days ago

Q1 2025 Johnson & Johnson Earnings Call

Stocks fizzle after two-day rally driven by bank earnings and tech

JNJ

Quartz

8 days ago

Stocks fizzle after two-day rally driven by bank earnings and tech

These Stocks Moved the Most Today: Bank of America, Citigroup, Netflix, Boeing, Tesla, HPE, Applied Digital, and More

JNJ

Barrons.com

8 days ago

These Stocks Moved the Most Today: Bank of America, Citigroup, Netflix, Boeing, Tesla, HPE, Applied Digital, and More

Johnson & Johnson Raises Sales Outlook as Pharma Sales Lead Q1 Beat

JNJ

GuruFocus.com

9 days ago

Johnson & Johnson Raises Sales Outlook as Pharma Sales Lead Q1 Beat

Johnson & Johnson Raises Full-Year Sales Guidance Following First-Quarter Beat

JNJ

MT Newswires

9 days ago

Johnson & Johnson Raises Full-Year Sales Guidance Following First-Quarter Beat

JNJ

MT Newswires

9 days ago

Sector Update: Health Care Stocks Lower to Flat Premarket Tuesday

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit

JNJ

Benzinga

9 days ago

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit

JNJ

MT Newswires

9 days ago

Sector Update: Health Care

NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates

JNJ

PR Newswire

9 days ago

NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates

JNJ

MT Newswires

9 days ago

Wall Street Digests Earnings as US Equity Futures Drop Pre-Bell

J&J Flexes Its Financial 'Bicep,' Hiking Guidance Despite Tariff Headwinds

JNJ

Investor's Business Daily

9 days ago

J&J Flexes Its Financial 'Bicep,' Hiking Guidance Despite Tariff Headwinds

Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds?

JNJ

Insider Monkey

10 days ago

Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds?

JNJ

MT Newswires

10 days ago

Raymond James Adjusts Price Target on Johnson & Johnson to $162 From $165, Keeps Outperform Rating

JNJ

Zacks

10 days ago

JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview

Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?

JNJ

Zacks

10 days ago

Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?

Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires

JNJ

Insider Monkey

10 days ago

Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires

Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?

JNJ

Insider Monkey

12 days ago

Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?

Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs

JNJ

Insider Monkey

12 days ago

Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs

JNJ

MT Newswires

12 days ago

Wolfe Research Cuts Johnson & Johnson Price Target to $175 From $190

Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings

JNJ

Zacks

13 days ago

Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings

J&J reports analysis from Phase III trial of plaque psoriasis treatment

JNJ

Clinical Trials Arena

13 days ago

J&J reports analysis from Phase III trial of plaque psoriasis treatment

JNJ

Motley Fool

13 days ago

2 Top Dividend Stocks to Buy Right Now

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

JNJ

Investor's Business Daily

13 days ago

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

JNJ

MT Newswires

14 days ago

BofA Adjusts Price Target on Johnson & Johnson to $159 From $171, Keeps Buy Rating

Seeking Clues to Johnson & Johnson (JNJ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

JNJ

Zacks

14 days ago

Seeking Clues to Johnson & Johnson (JNJ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

JNJ

MT Newswires

14 days ago

Johnson & Johnson Says Icotrokinra Achieves Clear Skin in Phase 3 Plaque Psoriasis Study

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

JNJ

Zacks

14 days ago

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Jim Cramer’s Take On Johnson & Johnson (JNJ): Are Litigation Fears Creating a Rare Buying Opportunity?

JNJ

Insider Monkey

14 days ago

Jim Cramer’s Take On Johnson & Johnson (JNJ): Are Litigation Fears Creating a Rare Buying Opportunity?

JNJ

PR Newswire

14 days ago

Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill

Stock Market Sell-Off Shopping Spree: 3 Top Dividend Stocks I Just Bought to Boost My Passive Income

JNJ

Motley Fool

14 days ago

Stock Market Sell-Off Shopping Spree: 3 Top Dividend Stocks I Just Bought to Boost My Passive Income

The Dow Crashed 4,260 Points in 3 Days: Here Are 3 Dow Stocks That Make for No-Brainer Buys Right Now

JNJ

Motley Fool

14 days ago

The Dow Crashed 4,260 Points in 3 Days: Here Are 3 Dow Stocks That Make for No-Brainer Buys Right Now

JNJ

Morningstar Research

14 days ago

Analyst Report: Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) Shares React as FDA Grants Multiple Designations to Nipocalimab

JNJ

Simply Wall St.

14 days ago

Johnson & Johnson (NYSE:JNJ) Shares React as FDA Grants Multiple Designations to Nipocalimab

JNJ

MT Newswires

15 days ago

Major Pharma Stocks Down Amid Tariff Turmoil

JNJ

MT Newswires

15 days ago

Morgan Stanley Adjusts PT on Johnson & Johnson to $164 From $163, Maintains Equalweight Rating

Johnson & Johnson (JNJ): Among Defensive Stocks Billionaire Ken Fisher is Betting On

JNJ

Insider Monkey

15 days ago

Johnson & Johnson (JNJ): Among Defensive Stocks Billionaire Ken Fisher is Betting On

Johnson & Johnson (JNJ) Stock Moves -0.52%: What You Should Know

JNJ

Zacks

15 days ago

Johnson & Johnson (JNJ) Stock Moves -0.52%: What You Should Know

Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients

JNJ

Benzinga

15 days ago

Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients

Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie

JNJ

GuruFocus.com

15 days ago

Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie

AAN 2025: J&J reveals data for nipocalimab, showing long-term disease control in MG

JNJ

Clinical Trials Arena

15 days ago

AAN 2025: J&J reveals data for nipocalimab, showing long-term disease control in MG

Walgreens, CVS, & US drugmakers make big moves: What to know

JNJ

Yahoo Finance Video

16 days ago

Walgreens, CVS, & US drugmakers make big moves: What to know

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

JNJ

Zacks

16 days ago

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

JNJ

MT Newswires

16 days ago

Johnson & Johnson Says New Data Support Nipocalimab's Long-Term Disease Control in Myasthenia Gravis

EC approves extension of indication for Janssen-Cilag’s Darzalex

JNJ

Pharmaceutical Technology

16 days ago

EC approves extension of indication for Janssen-Cilag’s Darzalex

Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia gravis (gMG)

JNJ

PR Newswire

16 days ago

Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia gravis (gMG)

JNJ

Morningstar Research

16 days ago

Analyst Report: Johnson & Johnson

Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference

JNJ

Business Wire

16 days ago

Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference

JNJ

MT Newswires

17 days ago

Johnson & Johnson's Janssen Says Subcutaneous Rybrevant Approved for 2 Indications in EU

J&J’s psoriatic arthritis therapy trial meets endpoints

JNJ

Clinical Trials Arena

17 days ago

J&J’s psoriatic arthritis therapy trial meets endpoints

Tariffs Stoke Fears That Hung Debt Will Return

JNJ

Bloomberg

18 days ago

Tariffs Stoke Fears That Hung Debt Will Return

Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study

JNJ

Benzinga

19 days ago

Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study

JNJ

Zacks

20 days ago

The Zacks Analyst Blog Highlights Johnson & Johnson and Pfizer

JNJ

MT Newswires

20 days ago

Wells Fargo Adjusts Price Target on Johnson & Johnson to $170 From $152, Keeps Equalweight Rating

JNJ

MT Newswires

20 days ago

Johnson & Johnson's Tremfya Achieves Key Endpoints in Psoriatic Arthritis Study

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis

JNJ

PR Newswire

20 days ago

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis

Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

JNJ

GuruFocus.com

20 days ago

Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

JNJ

Yahoo Finance

20 days ago

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street

JNJ

The Wall Street Journal

21 days ago

Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street

JNJ vs. PFE: Which Drug Giant is a Better Buy Now?

JNJ

Zacks

21 days ago

JNJ vs. PFE: Which Drug Giant is a Better Buy Now?

JNJ

Morningstar Research

21 days ago

Analyst Report: Johnson & Johnson

Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.

JNJ

Motley Fool

21 days ago

Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.

Big Pharma Avoids Worst-Case Tariff Scenario

JNJ

The Wall Street Journal

21 days ago

Big Pharma Avoids Worst-Case Tariff Scenario

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

JNJ

Zacks

21 days ago

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

JNJ

MT Newswires

21 days ago

Sector Update: Health Care Stocks Advance in Late Afternoon Trading

JNJ

MT Newswires

21 days ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

JNJ

MT Newswires

21 days ago

Sector Update: Health Care

JNJ

Investing.com

22 days ago

What's next for Johnson and Johnson after third failed attempt to settle talc laws

JNJ

MT Newswires

22 days ago

Latest Johnson & Johnson (JNJ) News on April 24, 2025

Share on Social Networks: